home / stock / bdtx / bdtx quote
Last: | $5.90 |
---|---|
Change Percent: | 0.54% |
Open: | $5.54 |
Close: | $5.90 |
High: | $6.19 |
Low: | $5.54 |
Volume: | 491,756 |
Last Trade Date Time: | 05/01/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5.9 | $5.54 | $5.9 | $6.19 | $5.54 | 491,756 | 05-01-2024 |
$5.57 | $5.8 | $5.57 | $5.8 | $5.34 | 483,607 | 04-30-2024 |
$5.865 | $5.85 | $5.865 | $6.16 | $5.47 | 3,049,555 | 04-29-2024 |
$5.89 | $5.16 | $5.89 | $5.95 | $5.16 | 567,043 | 04-26-2024 |
$5.11 | $4.97 | $5.11 | $5.13 | $4.93 | 233,076 | 04-25-2024 |
$5.06 | $5.04 | $5.06 | $5.175 | $4.87 | 362,011 | 04-24-2024 |
$5.01 | $5.05 | $5.01 | $5.27 | $4.97 | 355,971 | 04-23-2024 |
$5.02 | $5.28 | $5.02 | $5.47 | $4.96 | 512,721 | 04-22-2024 |
$5.26 | $5.17 | $5.26 | $5.57 | $5.17 | 386,747 | 04-19-2024 |
$5.3 | $5.72 | $5.3 | $5.72 | $5.13 | 1,862,382 | 04-18-2024 |
$5.7 | $5.32 | $5.7 | $6.21 | $5.32 | 920,934 | 04-17-2024 |
$5.38 | $5.25 | $5.38 | $5.4 | $5.13 | 318,764 | 04-16-2024 |
$5.22 | $5.24 | $5.22 | $5.405 | $5.2 | 377,980 | 04-15-2024 |
$5.24 | $5.57 | $5.24 | $5.6 | $5.2 | 475,633 | 04-12-2024 |
$5.57 | $5 | $5.57 | $5.595 | $5 | 572,072 | 04-11-2024 |
$4.98 | $5.16 | $4.98 | $5.21 | $4.812 | 415,014 | 04-10-2024 |
$5.36 | $5.41 | $5.36 | $5.62 | $5.28 | 448,709 | 04-09-2024 |
$5.35 | $5.24 | $5.35 | $5.445 | $4.89 | 450,573 | 04-08-2024 |
$5.06 | $5.1 | $5.06 | $5.22 | $4.98 | 310,917 | 04-05-2024 |
$5.11 | $5.02 | $5.11 | $5.56 | $5.02 | 549,087 | 04-04-2024 |
News, Short Squeeze, Breakout and More Instantly...
Black Diamond Therapeutics Inc. Company Name:
BDTX Stock Symbol:
NASDAQ Market:
2024-04-27 14:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (NASDAQ:BDTX), a clinical-stage oncology company developin...
CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today announced forthcoming presentations during the 2024...